These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10481843)

  • 21. Neurotoxicity of MDMA (ecstasy): beyond metabolism.
    Sprague JE; Nichols DE
    Trends Pharmacol Sci; 2005 Feb; 26(2):59-60; author reply 60-1. PubMed ID: 15681020
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of ecstasy on the body].
    Saarijärvi S; Lopperi M
    Duodecim; 2003; 119(13):1211-5. PubMed ID: 12908183
    [No Abstract]   [Full Text] [Related]  

  • 23. More about parkinsonism after taking ecstasy.
    Borg GJ
    N Engl J Med; 1999 Oct; 341(18):1400; author reply 1401. PubMed ID: 10577095
    [No Abstract]   [Full Text] [Related]  

  • 24. What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease?
    Kish SJ
    Mov Disord; 2003 Nov; 18(11):1219-23. PubMed ID: 14639660
    [No Abstract]   [Full Text] [Related]  

  • 25. An in vitro approach to assessing a potential drug interaction between MDMA (ecstasy) and caffeine.
    Downey C; Daly F; O'Boyle KM
    Toxicol In Vitro; 2014 Mar; 28(2):231-9. PubMed ID: 24211539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: the contemporary human and animal research perspective.
    Parrott AC; Marsden CA
    J Psychopharmacol; 2006 Mar; 20(2):143-6. PubMed ID: 16510473
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comment on R. Thomasius, M. Schmolke, D. Kraus: MDMA ("Ecstasy") use--an overview of psychiatric and medical sequelae].
    Gouzoulis-Mayfrank E; Hermle L; Kovar KA; Sass H
    Fortschr Neurol Psychiatr; 1999 Dec; 67(12):574-6. PubMed ID: 10683753
    [No Abstract]   [Full Text] [Related]  

  • 28. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positron emission tomography findings in heavy users of MDMA.
    Holland J
    Lancet; 1999 Feb; 353(9152):592-3. PubMed ID: 10029009
    [No Abstract]   [Full Text] [Related]  

  • 30. Neurotoxicity mechanisms of thioether ecstasy metabolites.
    Capela JP; Macedo C; Branco PS; Ferreira LM; Lobo AM; Fernandes E; Remião F; Bastos ML; Dirnagl U; Meisel A; Carvalho F
    Neuroscience; 2007 Jun; 146(4):1743-57. PubMed ID: 17467183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDMA: fact and fallacy, and the need to increase knowledge in both the scientific and popular press.
    Green AR
    Psychopharmacology (Berl); 2004 May; 173(3-4):231-3. PubMed ID: 14985917
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
    Biezonski DK; Meyer JS
    J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant hyperpyrexia in an MDMA ("Ecstasy") abuser.
    McCoy EP; Renfrew C; Johnston JR; Lavery G
    Ulster Med J; 1994 Apr; 63(1):103-7. PubMed ID: 8658983
    [No Abstract]   [Full Text] [Related]  

  • 34. Ecstasy: are animal data consistent between species and can they translate to humans?
    Easton N; Marsden CA
    J Psychopharmacol; 2006 Mar; 20(2):194-210. PubMed ID: 16510478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MDMA ("ecstasy") abuse as an example of dopamine neuroplasticity.
    Schenk S
    Neurosci Biobehav Rev; 2011 Apr; 35(5):1203-18. PubMed ID: 21184779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term neuropsychiatric consequences of "ecstasy" (MDMA): a review.
    Montoya AG; Sorrentino R; Lukas SE; Price BH
    Harv Rev Psychiatry; 2002; 10(4):212-20. PubMed ID: 12119307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neuropsychiatric disorders induced by MDMA ("Ecstasy")].
    Bailly D
    Encephale; 1999; 25(6):595-602. PubMed ID: 10668603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editorial note: MDMA-induced dopamine neurotoxicity.
    Warburton DM
    Psychopharmacology (Berl); 2004 Jan; 171(2):228. PubMed ID: 14634718
    [No Abstract]   [Full Text] [Related]  

  • 39. Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermia.
    Capela JP; Ruscher K; Lautenschlager M; Freyer D; Dirnagl U; Gaio AR; Bastos ML; Meisel A; Carvalho F
    Neuroscience; 2006; 139(3):1069-81. PubMed ID: 16504407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrovascular accident following MDMA ingestion.
    Muntan CD; Tuckler V
    J Med Toxicol; 2006 Mar; 2(1):16-8. PubMed ID: 18072107
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.